OrthoPediatrics to Participate in Upcoming Conferences
Rhea-AI Summary
OrthoPediatrics (Nasdaq: KIDS) will participate in two investor conferences in March 2026 with fireside chats on March 3 and March 10. An audio webcast will be available on the company's investor relations site, with a replay available for 90 days after each event.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – KIDS
On the day this news was published, KIDS gained 7.76%, reflecting a notable positive market reaction. This price movement added approximately $36M to the company's valuation, bringing the market cap to $506.56M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
KIDS rose 6.4% while sector momentum data flags this as a stock-specific move. Two peers in the scanner (OFIX, AVNS) showed modest upside, and several listed device peers (TMCI, ZIMV, BVS, CTKB, LAB) had smaller price changes, suggesting KIDS’ reaction is stronger than typical sector moves.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 12 | Earnings call schedule | Neutral | +1.0% | Announced timing for Q4 and full-year 2025 results release and call. |
| Feb 03 | Regulatory/tech expansion | Positive | -1.9% | FDA 510(k) clearance expanded use of iotaSOFT pediatric cochlear system. |
| Jan 12 | Preliminary results, guidance | Positive | +9.8% | Reported record 2025 revenue, improved free cash flow, and 2026 guidance. |
| Nov 13 | Product launches | Positive | -0.4% | Launched two PediHip bracing products for developmental hip dysplasia. |
| Nov 04 | Conference participation | Neutral | -1.3% | Outlined participation in several healthcare investor conferences with webcasts. |
Positive fundamental or product news has produced mixed reactions, with some strong gains but also instances where favorable updates were followed by modest declines.
Over the past several months, OrthoPediatrics has reported multiple growth milestones. On Jan 12, 2026, it announced record preliminary 2025 revenue of $236.1M and 2026 guidance, which preceded a 9.83% gain. Earlier, an enabling technology expansion on Feb 3, 2026 and specialty bracing launches on Nov 13, 2025 were followed by small declines. Prior conference-participation news on Nov 4, 2025 also saw a modest negative move, suggesting conference announcements alone have not consistently driven upside.
Market Pulse Summary
The stock moved +7.8% in the session following this news. A strong positive reaction aligns with recent evidence of fundamental momentum, including full-year 2025 revenue of $236.3 million and 2026 guidance of $262.0–$266.0 million. However, past conference announcements, such as those on Nov 4, 2025, saw limited follow-through. Investors have also contended with a 2025 net loss of $39.6 million, so sustained strength could depend on how effectively these appearances reinforce the growth and profitability trajectory.
Key Terms
audio webcast technical
AI-generated analysis. Not financial advice.
WARSAW, Ind., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences.
Event: TD Cowen 46th Annual Health Care Conference
Format: Fireside Chat
Date: Tuesday, March 3, 2026
Time: 1:10 pm ET
Event: The Citizens Life Sciences Conference
Format: Fireside Chat
Date: Tuesday, March 10, 2026
Time: 10:10 am ET
An audio webcast of the discussions will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionally, a replay will be available for 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
